Boston Scientific (NYSE: BSX) is picking up CeloNova Biosciences' interventional radiology portfolio, which makes medical devices used to deliver chemotherapy treatments, for $70 million.

The devices, called microspheres, can be loaded with chemotherapy or other drugs, and pumped through a catheter to treat cancerous tumors.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.